Body Image & Mental Health
Body image and mental health intersect obesity care throughout treatment with persistent stigma considerations. The session covers weight stigma in healthcare (the 2024 STRIDE study), body image after weight loss including excess skin and reconstructive surgery, depression and obesity bidirectionality, GLP-1 mental-health signal monitoring, body-image-focused therapy, and internalised weight bias measurement (WBIS-2F). Discussion addresses the 'former-fat-person' identity post-bariatric, eating disorder risk after rapid weight loss, the comparison of body-image outcomes across treatment modalities, the role of group therapy and peer support, and the integration of mental-health screening in routine obesity care.
- STRIDE healthcare stigma study
- Excess skin and reconstructive surgery
- Depression-obesity bidirectionality
- GLP-1 mental-health signal
- WBIS-2F internalised bias
- Former-fat-person identity
- Eating disorder risk
- Group therapy and peer support
Explore the full GSOD 2027 program
- 01GLP-1 & Incretin Therapies
- 02Bariatric Surgery
- 03Childhood & Adolescent Obesity
- 04Obesity Genetics & Epigenetics
- 05Metabolic Syndrome
- 06Behavioral & Lifestyle Interventions
- 07Gut Microbiome & Metabolism
- 08Health Equity in Obesity Care
- 09Policy, Environment & Prevention
- 10Weight Loss Maintenance
- 11Eating Disorders & Obesity
- 12Sarcopenic Obesity
- 13Hormonal Drivers
- 14Cardiometabolic Complications
- 15MASH & Obesity-Liver Axis
- 16Sleep & Obesity
- 17Workplace & School Programs
- 18Pharmacotherapy Pipeline
- 19Type 1 Diabetes
- 20Type 2 Diabetes
- 21Diabetic Retinopathy
- 22Diabetic Neuropathy
- 23Diabetic Kidney Disease
- 24Polycystic Ovary Syndrome
- 25Thyroid & Weight
- 26Insulin Resistance
- 27Lipid Metabolism
- 28Body Composition
- 30Diabetes in Pregnancy
- 31Telemedicine in Obesity
- 32Endocrine Disruptors
- 33Health Coaching
- 34Geriatric Obesity
- 35Stigma & Communication